For laboratory research use only. Not for human or veterinary use.
⚠ For research purposes only — This certificate relates to the referenced lot only and is not an approval for human or veterinary use.
← Back to Tirzepatide (GLP-2)
All certificates
Atlas LabsQuality Control · Released Records

Certificate of Analysis

DOC QC-COA-0110-A2702 · REV 1
ProductTirzepatide (GLP-2)
SKUATL-0110
LotA2702
FormatLyophilized · 30 mg
TestedAug 2026
Retest datePLACEHOLDER
CAS2023788-19-2
Storage−20 °C · desiccated
DispositionRELEASED

Test results

Release test results for Tirzepatide (GLP-2) lot A2702
TestMethodSpecificationResultVerdict
AppearanceVisual White to off-white solidWhite lyophilized solid PASS
PurityRP-HPLC, 220 nm ≥ 95.0%99.41% PASS
Net peptide contentHPLC 30 mg ± 2%30.6 mg PASS
IdentityESI-MS Observed mass conforms to theoreticalConforms PASS
Fentanyl screenImmunoassay Not detectedNot detected PASS
Heavy metalsICP-MS Not detectedNot detected PASS
SterilityPCR No growthNo growth PASS
EndotoxinLAL, USP <85> < 0.5 EU/mL< LOD PASS

Chromatogram · RP-HPLC, 220 nm

12.4 min · 99.41% RRT 1.28 · 0.09% 01530 min
FIG 1 · MAIN PEAK 12.4 MIN, 99.41% AREA · LARGEST IMPURITY 0.09% · PLACEHOLDER TRACE, REPLACE WITH LAB EXPORT

Conclusion. Lot A2702 of ATL-0110 meets all release specifications and is approved for distribution for laboratory research use only. Testing performed by ILS Laboratories, an independent ISO 17025 accredited laboratory.

Analyst · PLACEHOLDERILS Laboratories · Aug 2026
QC Release · PLACEHOLDERAtlas Labs · Aug 2026
VERIFY THIS DOCUMENT
getatlaspeptides.com/coa/a2702
CODE ATL-A2702-7M3D